Avalon to Release Fourth Quarter and Full Year 2006 Financial Results

GERMANTOWN, Md., March 14  /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. (NASDAQ:AVRX) today announced that it is scheduled to release financial results for the fourth quarter and full year of 2006, on Wednesday, March 21, 2007 after the close of the U.S. financial markets. The Company will host a conference call on Thursday, March 22, 2007 at 8:00 a.m. Eastern Time to provide a company update and discuss the financial results for the quarter and full year. Interested investors, analysts, members of the media and the general public can listen to the call live over the Internet from the investor section of the Company's website or by dialing the numbers listed below.

  Conference Call Details:
  ------------------------
  Dial-In:     866.383.8108 (U.S.)
               617.597.5343 (International)
  Passcode:    31676140
  Webcast:     Please go to http://www.avalonrx.com/, Investor Relations/
               Upcoming Presentations, within 15 minutes prior to the call
               and select the webcast link.
               The conference call replay will be available through April
               30, 2007 on Avalon's website (http://www.avalonrx.com/).

  About Avalon Pharmaceuticals


Avalon Pharmaceuticals is a biopharmaceutical company using its proprietary technology, AvalonRx(R), to discover and develop cancer therapeutics. Avalon has a lead product in Phase I clinical development (AVN944 - IMPDH inhibitor), as well as preclinical programs to discover inhibitors for the beta-catenin and aurora pathways now in late stage lead candidate optimization. Avalon also has discovery programs on modulators of survivin function and a drug discovery program targeting the MYC oncoprotein, one of the most important and previously intractable cancer targets. The company has value generating partnerships with Merck, MedImmune, Medarex and Novartis. Avalon Pharmaceuticals was established in 1999 and is headquartered in Germantown, Md. 

DATASOURCE: Avalon Pharmaceuticals, Inc.



CONTACT: Gary Lessing, Executive Vice President and CFO of Avalon

Pharmaceuticals, Inc., [phone], Fax [phone], or

 



Web site:  http://www.avalonrx.com/ 

Copyright